Can AI/machine learning-driven digital phenotyping facilitate global personalized medicine? In this Q&A, Vikram Patel, MBBS, PhD, the Paul Farmer Professor and chair of the Department of Global Health and Social Medicine at Harvard Medical School, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI can enhance assessment and treatment solutions across lower-income nations.

Related Content:

• One Day, AI Could Mean Better Mental Health for All

An Explosion of Food Is Medicine Research Could Change Health Care; Blockbuster Obesity Drugs Have Potential New Uses

Related Content:

• Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?
• Produce Prescriptions Sound Good, but Data to Support Them Are Lacking—That Could Soon Change

Douglas Drachman, MD, shares late-breaking research from the annual conference of the American College of Cardiology and World Congress of Cardiology in an interview with JAMA Medical News Director Jennifer Abbasi. Dr Drachman—who chaired this year’s conference—is an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division.

Related Content:

• Clinical Highlights From the American College of Cardiology’s 2024 Scientific Session